

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proline biosynthetic process (GO:0006561) | 4.71293075 |
| 2 | glycosphingolipid catabolic process (GO:0046479) | 4.57063773 |
| 3 | microglial cell activation (GO:0001774) | 4.54618199 |
| 4 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.53514184 |
| 5 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.42783030 |
| 6 | positive regulation of mast cell degranulation (GO:0043306) | 4.42783030 |
| 7 | positive regulation of mast cell activation (GO:0033005) | 4.40190591 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 4.38687387 |
| 9 | modulation by symbiont of host defense response (GO:0052031) | 4.38687387 |
| 10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.38687387 |
| 11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.38687387 |
| 12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.38687387 |
| 13 | modulation by symbiont of host immune response (GO:0052553) | 4.38687387 |
| 14 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.31893246 |
| 15 | regulation of macrophage chemotaxis (GO:0010758) | 4.31443687 |
| 16 | amino sugar catabolic process (GO:0046348) | 4.25470169 |
| 17 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 4.23010232 |
| 18 | regulation of mast cell degranulation (GO:0043304) | 4.21303257 |
| 19 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.17471364 |
| 20 | macrophage activation involved in immune response (GO:0002281) | 4.16682534 |
| 21 | oligosaccharide catabolic process (GO:0009313) | 4.15252899 |
| 22 | positive regulation of interferon-alpha production (GO:0032727) | 4.15042201 |
| 23 | detection of molecule of bacterial origin (GO:0032490) | 4.14981228 |
| 24 | glycolipid catabolic process (GO:0019377) | 4.09129850 |
| 25 | proline metabolic process (GO:0006560) | 4.08379776 |
| 26 | regulation of mononuclear cell migration (GO:0071675) | 4.04574438 |
| 27 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.95345220 |
| 28 | positive regulation of leukocyte degranulation (GO:0043302) | 3.92375432 |
| 29 | regulation of interferon-alpha production (GO:0032647) | 3.90146717 |
| 30 | detection of other organism (GO:0098543) | 3.89159571 |
| 31 | regulation of integrin activation (GO:0033623) | 3.82971806 |
| 32 | embryonic process involved in female pregnancy (GO:0060136) | 3.82155496 |
| 33 | N-acetylneuraminate metabolic process (GO:0006054) | 3.82031042 |
| 34 | sulfur amino acid catabolic process (GO:0000098) | 3.80624761 |
| 35 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.79733614 |
| 36 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.76976794 |
| 37 | complement activation, alternative pathway (GO:0006957) | 3.76103702 |
| 38 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.75151448 |
| 39 | cellular extravasation (GO:0045123) | 3.74171481 |
| 40 | regulation of mast cell activation (GO:0033003) | 3.73419677 |
| 41 | detection of external biotic stimulus (GO:0098581) | 3.73154805 |
| 42 | T-helper 1 type immune response (GO:0042088) | 3.70300196 |
| 43 | ceramide catabolic process (GO:0046514) | 3.66355786 |
| 44 | regulation of leukocyte degranulation (GO:0043300) | 3.65028910 |
| 45 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.58503484 |
| 46 | positive regulation of protein homooligomerization (GO:0032464) | 3.57902544 |
| 47 | detection of bacterium (GO:0016045) | 3.54594926 |
| 48 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.49781871 |
| 49 | negative regulation of cell killing (GO:0031342) | 3.49781871 |
| 50 | negative regulation of granulocyte differentiation (GO:0030853) | 3.47647698 |
| 51 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.44213111 |
| 52 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.44163792 |
| 53 | response to thyroid hormone (GO:0097066) | 3.42859910 |
| 54 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.41440295 |
| 55 | granulocyte activation (GO:0036230) | 3.37979276 |
| 56 | positive regulation of interferon-beta production (GO:0032728) | 3.36558535 |
| 57 | detection of biotic stimulus (GO:0009595) | 3.36183256 |
| 58 | cholesterol efflux (GO:0033344) | 3.34644174 |
| 59 | myeloid cell activation involved in immune response (GO:0002275) | 3.32830673 |
| 60 | macrophage activation (GO:0042116) | 3.28644275 |
| 61 | phospholipid efflux (GO:0033700) | 3.27139692 |
| 62 | tryptophan metabolic process (GO:0006568) | 3.26815487 |
| 63 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.26368616 |
| 64 | protein carboxylation (GO:0018214) | 3.26368616 |
| 65 | regulation of antigen processing and presentation (GO:0002577) | 3.23976878 |
| 66 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.23612445 |
| 67 | indole-containing compound catabolic process (GO:0042436) | 3.23345476 |
| 68 | indolalkylamine catabolic process (GO:0046218) | 3.23345476 |
| 69 | tryptophan catabolic process (GO:0006569) | 3.23345476 |
| 70 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.23326662 |
| 71 | L-phenylalanine metabolic process (GO:0006558) | 3.23326662 |
| 72 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.21593255 |
| 73 | aromatic amino acid family catabolic process (GO:0009074) | 3.19105994 |
| 74 | histamine secretion (GO:0001821) | 3.17687101 |
| 75 | regulation of protein activation cascade (GO:2000257) | 3.15940914 |
| 76 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.14742298 |
| 77 | L-phenylalanine catabolic process (GO:0006559) | 3.14742298 |
| 78 | barbed-end actin filament capping (GO:0051016) | 3.14429986 |
| 79 | immunoglobulin mediated immune response (GO:0016064) | 3.13663278 |
| 80 | adenosine receptor signaling pathway (GO:0001973) | 3.12510112 |
| 81 | cellular response to ATP (GO:0071318) | 3.12318963 |
| 82 | B cell mediated immunity (GO:0019724) | 3.11074719 |
| 83 | plasma lipoprotein particle assembly (GO:0034377) | 3.10802561 |
| 84 | neutrophil activation (GO:0042119) | 3.10224394 |
| 85 | plasma lipoprotein particle clearance (GO:0034381) | 3.10208649 |
| 86 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.09600614 |
| 87 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.07883608 |
| 88 | neutrophil activation involved in immune response (GO:0002283) | 3.07644657 |
| 89 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.07627935 |
| 90 | urea cycle (GO:0000050) | 3.06790822 |
| 91 | urea metabolic process (GO:0019627) | 3.06790822 |
| 92 | regulation of complement activation (GO:0030449) | 3.06454810 |
| 93 | respiratory burst (GO:0045730) | 3.05872370 |
| 94 | alkaloid metabolic process (GO:0009820) | 3.05869280 |
| 95 | regulation of hypersensitivity (GO:0002883) | 3.04672761 |
| 96 | regulation of cholesterol storage (GO:0010885) | 3.04616889 |
| 97 | regulation of cholesterol esterification (GO:0010872) | 3.03627364 |
| 98 | phagocytosis, engulfment (GO:0006911) | 3.01847522 |
| 99 | membrane invagination (GO:0010324) | 3.01711297 |
| 100 | transcription from mitochondrial promoter (GO:0006390) | 3.01551986 |
| 101 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.01012073 |
| 102 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.00370041 |
| 103 | glyoxylate metabolic process (GO:0046487) | 3.00226894 |
| 104 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.99089987 |
| 105 | membrane lipid catabolic process (GO:0046466) | 2.97602495 |
| 106 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.97521275 |
| 107 | kynurenine metabolic process (GO:0070189) | 2.96911376 |
| 108 | regulation of gamma-delta T cell activation (GO:0046643) | 2.96441535 |
| 109 | phospholipid homeostasis (GO:0055091) | 2.95460211 |
| 110 | acylglycerol homeostasis (GO:0055090) | 2.94360305 |
| 111 | triglyceride homeostasis (GO:0070328) | 2.94360305 |
| 112 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.94086995 |
| 113 | response to muramyl dipeptide (GO:0032495) | 2.93165830 |
| 114 | protein-lipid complex assembly (GO:0065005) | 2.92164274 |
| 115 | negative regulation of interleukin-12 production (GO:0032695) | 2.91686864 |
| 116 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.91350926 |
| 117 | embryonic placenta development (GO:0001892) | 2.89940773 |
| 118 | regulation of monocyte chemotaxis (GO:0090025) | 2.89642405 |
| 119 | phagosome maturation (GO:0090382) | 2.89488926 |
| 120 | response to peptidoglycan (GO:0032494) | 2.89149748 |
| 121 | sphingolipid catabolic process (GO:0030149) | 2.88148265 |
| 122 | macrophage differentiation (GO:0030225) | 2.86550789 |
| 123 | cytolysis (GO:0019835) | 2.85333869 |
| 124 | regulation of T cell tolerance induction (GO:0002664) | 2.85141411 |
| 125 | positive regulation of antigen processing and presentation (GO:0002579) | 2.84527688 |
| 126 | intestinal cholesterol absorption (GO:0030299) | 2.83146646 |
| 127 | regulation of regulated secretory pathway (GO:1903305) | 2.83127089 |
| 128 | myeloid dendritic cell differentiation (GO:0043011) | 2.83116503 |
| 129 | reverse cholesterol transport (GO:0043691) | 2.81866426 |
| 130 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.81625140 |
| 131 | nitrogen cycle metabolic process (GO:0071941) | 2.81605249 |
| 132 | cellular response to zinc ion (GO:0071294) | 2.81378014 |
| 133 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.80866250 |
| 134 | monocyte chemotaxis (GO:0002548) | 2.80278002 |
| 135 | high-density lipoprotein particle remodeling (GO:0034375) | 2.80059096 |
| 136 | bile acid metabolic process (GO:0008206) | 2.79930270 |
| 137 | regulation of protein homooligomerization (GO:0032462) | 2.79500408 |
| 138 | homocysteine metabolic process (GO:0050667) | 2.77768770 |
| 139 | positive regulation of chemokine secretion (GO:0090197) | 2.76342546 |
| 140 | response to host immune response (GO:0052572) | 2.73261580 |
| 141 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.73261580 |
| 142 | negative regulation of interleukin-17 production (GO:0032700) | 2.73197528 |
| 143 | complement activation (GO:0006956) | 2.72476132 |
| 144 | myeloid dendritic cell activation (GO:0001773) | 2.71848997 |
| 145 | low-density lipoprotein particle remodeling (GO:0034374) | 2.71036947 |
| 146 | mannose metabolic process (GO:0006013) | 2.70754969 |
| 147 | germinal center formation (GO:0002467) | 2.69330147 |
| 148 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.68215253 |
| 149 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.68152893 |
| 150 | positive regulation of regulated secretory pathway (GO:1903307) | 2.67364640 |
| 151 | positive regulation of type 2 immune response (GO:0002830) | 2.67228842 |
| 152 | NAD biosynthetic process (GO:0009435) | 2.67174136 |
| 153 | I-kappaB phosphorylation (GO:0007252) | 2.66695372 |
| 154 | bile acid biosynthetic process (GO:0006699) | 2.66628395 |
| 155 | positive regulation of B cell differentiation (GO:0045579) | 2.66411987 |
| 156 | complement activation, classical pathway (GO:0006958) | 2.66386508 |
| 157 | regulation of tolerance induction (GO:0002643) | 2.65892618 |
| 158 | apoptotic cell clearance (GO:0043277) | 2.65111714 |
| 159 | lytic vacuole organization (GO:0080171) | 2.64592942 |
| 160 | lysosome organization (GO:0007040) | 2.64592942 |
| 161 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.64342132 |
| 162 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.63661787 |
| 163 | bile acid and bile salt transport (GO:0015721) | 2.63489135 |
| 164 | cellular response to arsenic-containing substance (GO:0071243) | 2.62623352 |
| 165 | regulation of interferon-beta production (GO:0032648) | 2.61896127 |
| 166 | myeloid leukocyte activation (GO:0002274) | 2.61833962 |
| 167 | positive regulation of cholesterol efflux (GO:0010875) | 2.59768876 |
| 168 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.59327432 |
| 169 | lipoprotein metabolic process (GO:0042157) | 2.58176078 |
| 170 | regulation of triglyceride catabolic process (GO:0010896) | 2.57952380 |
| 171 | protein-lipid complex remodeling (GO:0034368) | 2.57047106 |
| 172 | macromolecular complex remodeling (GO:0034367) | 2.57047106 |
| 173 | plasma lipoprotein particle remodeling (GO:0034369) | 2.57047106 |
| 174 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.55858874 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.68982166 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.56143582 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.54846937 |
| 4 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.12450114 |
| 5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.59144187 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.49633839 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.38203548 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.05668925 |
| 9 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.98762678 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.95530224 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.73981641 |
| 12 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.71081419 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.64097868 |
| 14 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.52132824 |
| 15 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.44218288 |
| 16 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.38950818 |
| 17 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.22884871 |
| 18 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.18591174 |
| 19 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.12848033 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.12545875 |
| 21 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.06596978 |
| 22 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.06483162 |
| 23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.03528329 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.00182128 |
| 25 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.97344518 |
| 26 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.94187511 |
| 27 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.94187511 |
| 28 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.94187511 |
| 29 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86262893 |
| 30 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.79457336 |
| 31 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.78538286 |
| 32 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.75033427 |
| 33 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.69660747 |
| 34 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69450560 |
| 35 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.65811165 |
| 36 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.64566417 |
| 37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.58946814 |
| 38 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.55902435 |
| 39 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.51992981 |
| 40 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.49947401 |
| 41 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.49129623 |
| 42 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.47168989 |
| 43 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.45362285 |
| 44 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.45013283 |
| 45 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.44066926 |
| 46 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39315309 |
| 47 | GATA1_22025678_ChIP-Seq_K562_Human | 1.37922471 |
| 48 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.35482811 |
| 49 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.33673573 |
| 50 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.31770685 |
| 51 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.31179756 |
| 52 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.30866261 |
| 53 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.30806970 |
| 54 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.30405864 |
| 55 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27460399 |
| 56 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.27011268 |
| 57 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26991387 |
| 58 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25992081 |
| 59 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.25747340 |
| 60 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.24712225 |
| 61 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.24092052 |
| 62 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.23803117 |
| 63 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.22327781 |
| 64 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.21907700 |
| 65 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.20948022 |
| 66 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.20099307 |
| 67 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.20032803 |
| 68 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.19813085 |
| 69 | MYB_26560356_Chip-Seq_TH2_Human | 1.15112424 |
| 70 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13679885 |
| 71 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.13185954 |
| 72 | GATA1_19941826_ChIP-Seq_K562_Human | 1.13162499 |
| 73 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11745995 |
| 74 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.10454628 |
| 75 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.09491750 |
| 76 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.09296507 |
| 77 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.09005076 |
| 78 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.08122397 |
| 79 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08118188 |
| 80 | MAF_26560356_Chip-Seq_TH1_Human | 1.07521834 |
| 81 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07401887 |
| 82 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06768882 |
| 83 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.06363932 |
| 84 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05942543 |
| 85 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.05829337 |
| 86 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.03793799 |
| 87 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.03771130 |
| 88 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03415915 |
| 89 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.03258889 |
| 90 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01877739 |
| 91 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.01647201 |
| 92 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.99778008 |
| 93 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.99189228 |
| 94 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98588399 |
| 95 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.98452722 |
| 96 | UTX_26944678_Chip-Seq_JUKART_Human | 0.97845873 |
| 97 | GATA3_26560356_Chip-Seq_TH2_Human | 0.96762122 |
| 98 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.95543953 |
| 99 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.94802185 |
| 100 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.94550413 |
| 101 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.94532556 |
| 102 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.91854960 |
| 103 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91794339 |
| 104 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.89650246 |
| 105 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.89098633 |
| 106 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.89058071 |
| 107 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88921703 |
| 108 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.88314483 |
| 109 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.88017086 |
| 110 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.87846122 |
| 111 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.87021688 |
| 112 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.86841197 |
| 113 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.86771236 |
| 114 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.86508822 |
| 115 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86220209 |
| 116 | MAF_26560356_Chip-Seq_TH2_Human | 0.85792474 |
| 117 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.84842667 |
| 118 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84491331 |
| 119 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.84294531 |
| 120 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.84013399 |
| 121 | MYB_26560356_Chip-Seq_TH1_Human | 0.83272555 |
| 122 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.82583269 |
| 123 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.82152775 |
| 124 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81791755 |
| 125 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.81511278 |
| 126 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.81489514 |
| 127 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.80717569 |
| 128 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.80652388 |
| 129 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.78977226 |
| 130 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.77504527 |
| 131 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.73356862 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 3.80879639 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 3.64836844 |
| 3 | MP0003191_abnormal_cellular_cholesterol | 3.61752127 |
| 4 | MP0005360_urolithiasis | 3.48320257 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 3.46520981 |
| 6 | MP0005365_abnormal_bile_salt | 3.46011873 |
| 7 | MP0006082_CNS_inflammation | 3.45218188 |
| 8 | MP0009840_abnormal_foam_cell | 3.33836811 |
| 9 | MP0001835_abnormal_antigen_presentation | 2.87555494 |
| 10 | MP0003172_abnormal_lysosome_physiology | 2.75328588 |
| 11 | MP0009278_abnormal_bone_marrow | 2.54140683 |
| 12 | MP0003252_abnormal_bile_duct | 2.42585173 |
| 13 | MP0003300_gastrointestinal_ulcer | 2.35652780 |
| 14 | MP0003436_decreased_susceptibility_to | 2.26257599 |
| 15 | MP0005464_abnormal_platelet_physiology | 2.16587477 |
| 16 | MP0002419_abnormal_innate_immunity | 2.09315330 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.02940193 |
| 18 | MP0003724_increased_susceptibility_to | 2.02394975 |
| 19 | MP0000685_abnormal_immune_system | 1.93448744 |
| 20 | MP0008875_abnormal_xenobiotic_pharmacok | 1.92872386 |
| 21 | MP0003075_altered_response_to | 1.83070852 |
| 22 | MP0010329_abnormal_lipoprotein_level | 1.79714118 |
| 23 | MP0003690_abnormal_glial_cell | 1.74861321 |
| 24 | MP0005025_abnormal_response_to | 1.71822958 |
| 25 | MP0004019_abnormal_vitamin_homeostasis | 1.69192299 |
| 26 | MP0005310_abnormal_salivary_gland | 1.67814656 |
| 27 | MP0005671_abnormal_response_to | 1.67043854 |
| 28 | MP0000609_abnormal_liver_physiology | 1.64635117 |
| 29 | MP0003303_peritoneal_inflammation | 1.62339173 |
| 30 | MP0009785_altered_susceptibility_to | 1.61318446 |
| 31 | MP0005670_abnormal_white_adipose | 1.56263673 |
| 32 | MP0005000_abnormal_immune_tolerance | 1.56049751 |
| 33 | MP0005171_absent_coat_pigmentation | 1.51573422 |
| 34 | MP0008469_abnormal_protein_level | 1.51555116 |
| 35 | MP0001800_abnormal_humoral_immune | 1.50071041 |
| 36 | MP0005387_immune_system_phenotype | 1.49184694 |
| 37 | MP0001790_abnormal_immune_system | 1.49184694 |
| 38 | MP0002452_abnormal_antigen_presenting | 1.48355984 |
| 39 | MP0005397_hematopoietic_system_phenotyp | 1.45026928 |
| 40 | MP0001545_abnormal_hematopoietic_system | 1.45026928 |
| 41 | MP0002723_abnormal_immune_serum | 1.41131504 |
| 42 | MP0002405_respiratory_system_inflammati | 1.40905184 |
| 43 | MP0008004_abnormal_stomach_pH | 1.40622985 |
| 44 | MP0002138_abnormal_hepatobiliary_system | 1.36693059 |
| 45 | MP0009764_decreased_sensitivity_to | 1.36227591 |
| 46 | MP0003045_fibrosis | 1.35813401 |
| 47 | MP0005332_abnormal_amino_acid | 1.35320453 |
| 48 | MP0003828_pulmonary_edema | 1.32322215 |
| 49 | MP0000371_diluted_coat_color | 1.32278317 |
| 50 | MP0001853_heart_inflammation | 1.32022201 |
| 51 | MP0002837_dystrophic_cardiac_calcinosis | 1.30451890 |
| 52 | MP0002118_abnormal_lipid_homeostasis | 1.29560784 |
| 53 | MP0001845_abnormal_inflammatory_respons | 1.29316937 |
| 54 | MP0001533_abnormal_skeleton_physiology | 1.28228073 |
| 55 | MP0001666_abnormal_nutrient_absorption | 1.25920898 |
| 56 | MP0005319_abnormal_enzyme/_coenzyme | 1.25702354 |
| 57 | MP0005083_abnormal_biliary_tract | 1.23605280 |
| 58 | MP0005451_abnormal_body_composition | 1.22472959 |
| 59 | MP0000343_altered_response_to | 1.22425978 |
| 60 | MP0002166_altered_tumor_susceptibility | 1.21915074 |
| 61 | MP0003453_abnormal_keratinocyte_physiol | 1.20622395 |
| 62 | MP0008260_abnormal_autophagy | 1.20420915 |
| 63 | MP0000858_altered_metastatic_potential | 1.16703800 |
| 64 | MP0002009_preneoplasia | 1.16279722 |
| 65 | MP0004510_myositis | 1.15297891 |
| 66 | MP0009115_abnormal_fat_cell | 1.14973406 |
| 67 | MP0000920_abnormal_myelination | 1.14923912 |
| 68 | MP0005174_abnormal_tail_pigmentation | 1.14638706 |
| 69 | MP0008057_abnormal_DNA_replication | 1.13937184 |
| 70 | MP0002254_reproductive_system_inflammat | 1.13007062 |
| 71 | MP0004130_abnormal_muscle_cell | 1.11497921 |
| 72 | MP0001819_abnormal_immune_cell | 1.08017271 |
| 73 | MP0003329_amyloid_beta_deposits | 1.06329911 |
| 74 | MP0003806_abnormal_nucleotide_metabolis | 1.05149801 |
| 75 | MP0000604_amyloidosis | 1.04609831 |
| 76 | MP0002420_abnormal_adaptive_immunity | 1.04167212 |
| 77 | MP0010155_abnormal_intestine_physiology | 1.03428157 |
| 78 | MP0009763_increased_sensitivity_to | 1.02443633 |
| 79 | MP0002277_abnormal_respiratory_mucosa | 1.02144713 |
| 80 | MP0003656_abnormal_erythrocyte_physiolo | 1.00714072 |
| 81 | MP0001764_abnormal_homeostasis | 0.99340420 |
| 82 | MP0002006_tumorigenesis | 0.97736244 |
| 83 | MP0005076_abnormal_cell_differentiation | 0.97253618 |
| 84 | MP0000465_gastrointestinal_hemorrhage | 0.96807446 |
| 85 | MP0005167_abnormal_blood-brain_barrier | 0.96430536 |
| 86 | MP0002998_abnormal_bone_remodeling | 0.96416330 |
| 87 | MP0000015_abnormal_ear_pigmentation | 0.96245811 |
| 88 | MP0005166_decreased_susceptibility_to | 0.95664411 |
| 89 | MP0006054_spinal_hemorrhage | 0.93687395 |
| 90 | MP0003183_abnormal_peptide_metabolism | 0.93388219 |
| 91 | MP0000598_abnormal_liver_morphology | 0.93325641 |
| 92 | MP0000689_abnormal_spleen_morphology | 0.91190330 |
| 93 | MP0002398_abnormal_bone_marrow | 0.91035810 |
| 94 | MP0002429_abnormal_blood_cell | 0.90057675 |
| 95 | MP0003705_abnormal_hypodermis_morpholog | 0.88685397 |
| 96 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.88364546 |
| 97 | MP0002928_abnormal_bile_duct | 0.86925895 |
| 98 | MP0002971_abnormal_brown_adipose | 0.86913339 |
| 99 | MP0005164_abnormal_response_to | 0.85464877 |
| 100 | MP0004883_abnormal_blood_vessel | 0.85204407 |
| 101 | MP0003186_abnormal_redox_activity | 0.84879110 |
| 102 | MP0002332_abnormal_exercise_endurance | 0.84185739 |
| 103 | MP0003448_altered_tumor_morphology | 0.83920912 |
| 104 | MP0000249_abnormal_blood_vessel | 0.82873272 |
| 105 | MP0005334_abnormal_fat_pad | 0.82198789 |
| 106 | MP0004947_skin_inflammation | 0.82185594 |
| 107 | MP0003195_calcinosis | 0.81638654 |
| 108 | MP0000716_abnormal_immune_system | 0.81302753 |
| 109 | MP0009333_abnormal_splenocyte_physiolog | 0.80159594 |
| 110 | MP0000569_abnormal_digit_pigmentation | 0.79929097 |
| 111 | MP0003795_abnormal_bone_structure | 0.79911921 |
| 112 | MP0005390_skeleton_phenotype | 0.79605369 |
| 113 | MP0010307_abnormal_tumor_latency | 0.78824710 |
| 114 | MP0003879_abnormal_hair_cell | 0.77816022 |
| 115 | MP0005023_abnormal_wound_healing | 0.77748711 |
| 116 | MP0002722_abnormal_immune_system | 0.75429974 |
| 117 | MP0002090_abnormal_vision | 0.75036358 |
| 118 | MP0005165_increased_susceptibility_to | 0.74674080 |
| 119 | MP0009643_abnormal_urine_homeostasis | 0.74505848 |
| 120 | MP0001851_eye_inflammation | 0.73968198 |
| 121 | MP0005647_abnormal_sex_gland | 0.72410625 |
| 122 | MP0005075_abnormal_melanosome_morpholog | 0.71934716 |
| 123 | MP0002933_joint_inflammation | 0.70397966 |
| 124 | MP0005666_abnormal_adipose_tissue | 0.69866647 |
| 125 | MP0001663_abnormal_digestive_system | 0.68204739 |
| 126 | MP0003634_abnormal_glial_cell | 0.64864937 |
| 127 | MP0003633_abnormal_nervous_system | 0.62964087 |
| 128 | MP0003279_aneurysm | 0.61894946 |
| 129 | MP0002877_abnormal_melanocyte_morpholog | 0.58939401 |
| 130 | MP0005595_abnormal_vascular_smooth | 0.57069022 |
| 131 | MP0008874_decreased_physiological_sensi | 0.55797306 |
| 132 | MP0003091_abnormal_cell_migration | 0.51577637 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 7.42509655 |
| 2 | Complement deficiency (HP:0004431) | 6.29956690 |
| 3 | Glomerulonephritis (HP:0000099) | 5.84718322 |
| 4 | Abnormality of complement system (HP:0005339) | 5.17376167 |
| 5 | Disinhibition (HP:0000734) | 4.60605512 |
| 6 | Pustule (HP:0200039) | 4.32554771 |
| 7 | Loss of speech (HP:0002371) | 4.24351598 |
| 8 | Mutism (HP:0002300) | 4.18047123 |
| 9 | Myocardial infarction (HP:0001658) | 4.17933941 |
| 10 | Dysostosis multiplex (HP:0000943) | 4.17843805 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.16155545 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 4.09918307 |
| 13 | Recurrent abscess formation (HP:0002722) | 4.00514737 |
| 14 | Nephritis (HP:0000123) | 3.96000987 |
| 15 | Mucopolysacchariduria (HP:0008155) | 3.80550731 |
| 16 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.80550731 |
| 17 | Eczematoid dermatitis (HP:0000976) | 3.70212187 |
| 18 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.61493478 |
| 19 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.61493478 |
| 20 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.61493478 |
| 21 | Increased IgM level (HP:0003496) | 3.55647419 |
| 22 | Axonal loss (HP:0003447) | 3.47429863 |
| 23 | Xanthomatosis (HP:0000991) | 3.38453759 |
| 24 | Joint hemorrhage (HP:0005261) | 3.34595811 |
| 25 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.24251584 |
| 26 | Vacuolated lymphocytes (HP:0001922) | 3.23196731 |
| 27 | Neurofibrillary tangles (HP:0002185) | 3.14987695 |
| 28 | Rectovaginal fistula (HP:0000143) | 3.14746028 |
| 29 | Rectal fistula (HP:0100590) | 3.14746028 |
| 30 | Intestinal fistula (HP:0100819) | 3.12391719 |
| 31 | Intrahepatic cholestasis (HP:0001406) | 3.11139968 |
| 32 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.10363168 |
| 33 | Vaginal fistula (HP:0004320) | 3.07432500 |
| 34 | Alopecia of scalp (HP:0002293) | 3.06177303 |
| 35 | Hypochromic microcytic anemia (HP:0004840) | 3.02406573 |
| 36 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.00080088 |
| 37 | Stomatitis (HP:0010280) | 2.99024815 |
| 38 | Purpura (HP:0000979) | 2.98946340 |
| 39 | Deep venous thrombosis (HP:0002625) | 2.98392137 |
| 40 | Myositis (HP:0100614) | 2.96172177 |
| 41 | Nuclear cataract (HP:0100018) | 2.95352059 |
| 42 | Orchitis (HP:0100796) | 2.94141620 |
| 43 | Prolonged partial thromboplastin time (HP:0003645) | 2.92735510 |
| 44 | Agnosia (HP:0010524) | 2.90876570 |
| 45 | Obstructive lung disease (HP:0006536) | 2.88966350 |
| 46 | Chronic obstructive pulmonary disease (HP:0006510) | 2.88966350 |
| 47 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.85941504 |
| 48 | Colitis (HP:0002583) | 2.82955782 |
| 49 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.77866489 |
| 50 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.77866489 |
| 51 | Abnormality of glycolipid metabolism (HP:0010969) | 2.77866489 |
| 52 | Increased cerebral lipofuscin (HP:0011813) | 2.74349166 |
| 53 | Autoimmune thrombocytopenia (HP:0001973) | 2.73570161 |
| 54 | Optic neuritis (HP:0100653) | 2.73405983 |
| 55 | Retrobulbar optic neuritis (HP:0100654) | 2.73405983 |
| 56 | Inappropriate behavior (HP:0000719) | 2.66653388 |
| 57 | Cerebral aneurysm (HP:0004944) | 2.65827359 |
| 58 | Hypobetalipoproteinemia (HP:0003563) | 2.64664862 |
| 59 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.64162578 |
| 60 | Urethral obstruction (HP:0000796) | 2.61974062 |
| 61 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.59304275 |
| 62 | Neuronal loss in central nervous system (HP:0002529) | 2.54377330 |
| 63 | Polycythemia (HP:0001901) | 2.51250393 |
| 64 | Increased serum ferritin (HP:0003281) | 2.49980407 |
| 65 | Turricephaly (HP:0000262) | 2.49173683 |
| 66 | Hypercholesterolemia (HP:0003124) | 2.48606600 |
| 67 | Apathy (HP:0000741) | 2.43383975 |
| 68 | Upper motor neuron abnormality (HP:0002127) | 2.42904435 |
| 69 | Diminished motivation (HP:0000745) | 2.40972952 |
| 70 | Recurrent skin infections (HP:0001581) | 2.40859781 |
| 71 | Abnormality of macrophages (HP:0004311) | 2.38242814 |
| 72 | Thick nail (HP:0001805) | 2.37485460 |
| 73 | Albinism (HP:0001022) | 2.36444105 |
| 74 | Progressive neurologic deterioration (HP:0002344) | 2.33259169 |
| 75 | Hemoptysis (HP:0002105) | 2.33017666 |
| 76 | Petechiae (HP:0000967) | 2.32494645 |
| 77 | Epidermoid cyst (HP:0200040) | 2.31681716 |
| 78 | Peripheral demyelination (HP:0011096) | 2.29948173 |
| 79 | Pathologic fracture (HP:0002756) | 2.29549225 |
| 80 | Pulmonary infiltrates (HP:0002113) | 2.28635270 |
| 81 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.27942433 |
| 82 | Recurrent fungal infections (HP:0002841) | 2.25971086 |
| 83 | Hyperlipoproteinemia (HP:0010980) | 2.25960259 |
| 84 | Hypolipoproteinemia (HP:0010981) | 2.25660734 |
| 85 | Retinal atrophy (HP:0001105) | 2.25340124 |
| 86 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.23041600 |
| 87 | Recurrent cutaneous fungal infections (HP:0011370) | 2.23041600 |
| 88 | Asymmetric septal hypertrophy (HP:0001670) | 2.20381238 |
| 89 | Hypoalphalipoproteinemia (HP:0003233) | 2.20246407 |
| 90 | Urticaria (HP:0001025) | 2.20045023 |
| 91 | Global brain atrophy (HP:0002283) | 2.19703799 |
| 92 | Dementia (HP:0000726) | 2.18288771 |
| 93 | Intestinal atresia (HP:0011100) | 2.18265040 |
| 94 | Orthostatic hypotension (HP:0001278) | 2.17744619 |
| 95 | Meningitis (HP:0001287) | 2.17022976 |
| 96 | Abnormality of the common coagulation pathway (HP:0010990) | 2.16571918 |
| 97 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.15727807 |
| 98 | Hyperammonemia (HP:0001987) | 2.15258661 |
| 99 | Cerebral inclusion bodies (HP:0100314) | 2.15114187 |
| 100 | Cardiomegaly (HP:0001640) | 2.14187079 |
| 101 | Lower limb hyperreflexia (HP:0002395) | 2.14040905 |
| 102 | Personality changes (HP:0000751) | 2.13545846 |
| 103 | Abnormality of iron homeostasis (HP:0011031) | 2.13330524 |
| 104 | Amyloidosis (HP:0011034) | 2.12748232 |
| 105 | Fat malabsorption (HP:0002630) | 2.11921407 |
| 106 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.09888474 |
| 107 | Hypokinesia (HP:0002375) | 2.09082648 |
| 108 | Spontaneous hematomas (HP:0007420) | 2.08292314 |
| 109 | Hemorrhage of the eye (HP:0011885) | 2.06807380 |
| 110 | Esophageal varix (HP:0002040) | 2.05828998 |
| 111 | Conjunctival telangiectasia (HP:0000524) | 2.05659173 |
| 112 | Malnutrition (HP:0004395) | 2.02993111 |
| 113 | Polyneuropathy (HP:0001271) | 2.02870030 |
| 114 | Gingival bleeding (HP:0000225) | 2.02762935 |
| 115 | Increased IgE level (HP:0003212) | 2.00855442 |
| 116 | Gingivitis (HP:0000230) | 2.00421210 |
| 117 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.00233544 |
| 118 | Metaphyseal irregularity (HP:0003025) | 1.99559860 |
| 119 | Progressive visual loss (HP:0000529) | 1.98912783 |
| 120 | Mediastinal lymphadenopathy (HP:0100721) | 1.98083524 |
| 121 | Vasculitis (HP:0002633) | 1.96989669 |
| 122 | Prolonged neonatal jaundice (HP:0006579) | 1.95981135 |
| 123 | Abnormality of male internal genitalia (HP:0000022) | 1.94222460 |
| 124 | Ketosis (HP:0001946) | 1.92950044 |
| 125 | Prostate neoplasm (HP:0100787) | 1.92136489 |
| 126 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.91763108 |
| 127 | Bone cyst (HP:0012062) | 1.91339941 |
| 128 | Inflammation of the large intestine (HP:0002037) | 1.91019101 |
| 129 | Anorexia (HP:0002039) | 1.90757850 |
| 130 | Coarse hair (HP:0002208) | 1.89994516 |
| 131 | Abnormality of the periventricular white matter (HP:0002518) | 1.89820516 |
| 132 | Hydroxyprolinuria (HP:0003080) | 1.89457078 |
| 133 | Abnormality of proline metabolism (HP:0010907) | 1.89457078 |
| 134 | Periodontitis (HP:0000704) | 1.89363460 |
| 135 | Keratoconjunctivitis sicca (HP:0001097) | 1.89346771 |
| 136 | Thoracic kyphosis (HP:0002942) | 1.88767933 |
| 137 | Hematochezia (HP:0002573) | 1.88732286 |
| 138 | Recurrent viral infections (HP:0004429) | 1.87810617 |
| 139 | Hepatosplenomegaly (HP:0001433) | 1.87462331 |
| 140 | Hyperglycinuria (HP:0003108) | 1.86971810 |
| 141 | Memory impairment (HP:0002354) | 1.85424182 |
| 142 | Increased CSF protein (HP:0002922) | 1.83960380 |
| 143 | Hypochromic anemia (HP:0001931) | 1.83704706 |
| 144 | Joint stiffness (HP:0001387) | 1.83207004 |
| 145 | IgA deficiency (HP:0002720) | 1.83176320 |
| 146 | Rib fusion (HP:0000902) | 1.81861447 |
| 147 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.81187303 |
| 148 | Basal ganglia calcification (HP:0002135) | 1.80051331 |
| 149 | Abnormality of methionine metabolism (HP:0010901) | 1.79392598 |
| 150 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.78935597 |
| 151 | Supranuclear gaze palsy (HP:0000605) | 1.78599899 |
| 152 | Epistaxis (HP:0000421) | 1.76497453 |
| 153 | Restrictive lung disease (HP:0002091) | 1.76137888 |
| 154 | T lymphocytopenia (HP:0005403) | 1.74908195 |
| 155 | Pulmonary embolism (HP:0002204) | 1.74700623 |
| 156 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.72581718 |
| 157 | Keratoconjunctivitis (HP:0001096) | 1.71591426 |
| 158 | Bone pain (HP:0002653) | 1.70676310 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 4.80707950 |
| 2 | ICK | 4.11268702 |
| 3 | TGFBR2 | 3.83719678 |
| 4 | MAP3K6 | 2.98528906 |
| 5 | TYK2 | 2.74585867 |
| 6 | CSK | 2.54779058 |
| 7 | DDR2 | 2.53980307 |
| 8 | MATK | 2.46404560 |
| 9 | FGR | 2.26575384 |
| 10 | MAP3K11 | 2.22791717 |
| 11 | MAP3K14 | 2.14737171 |
| 12 | BLK | 2.13741463 |
| 13 | PIM2 | 2.06983382 |
| 14 | PINK1 | 2.06140334 |
| 15 | NME2 | 2.06134420 |
| 16 | GRK7 | 2.04926095 |
| 17 | ACVR1B | 2.03124030 |
| 18 | CAMKK2 | 1.98578378 |
| 19 | MAP3K3 | 1.97769128 |
| 20 | TBK1 | 1.96929893 |
| 21 | RIPK4 | 1.91662962 |
| 22 | IRAK3 | 1.83150242 |
| 23 | YES1 | 1.75705050 |
| 24 | BMX | 1.69414861 |
| 25 | ERN1 | 1.68798373 |
| 26 | FES | 1.63194537 |
| 27 | CAMK1D | 1.61900278 |
| 28 | IRAK4 | 1.56843007 |
| 29 | IKBKB | 1.55634194 |
| 30 | TAOK1 | 1.47568101 |
| 31 | JAK1 | 1.42884624 |
| 32 | CDK6 | 1.42058806 |
| 33 | CSF1R | 1.40452165 |
| 34 | TRPM7 | 1.35384140 |
| 35 | PRPF4B | 1.33733050 |
| 36 | PDGFRA | 1.30313803 |
| 37 | DYRK1B | 1.24685320 |
| 38 | MAP4K1 | 1.24036840 |
| 39 | TAOK2 | 1.23396541 |
| 40 | KIT | 1.23339543 |
| 41 | TNK2 | 1.22393974 |
| 42 | MAPK11 | 1.22298976 |
| 43 | PIM1 | 1.18896455 |
| 44 | FGFR4 | 1.17414936 |
| 45 | MARK3 | 1.16941140 |
| 46 | ZAP70 | 1.16459675 |
| 47 | MAP3K1 | 1.16320536 |
| 48 | IKBKE | 1.12471535 |
| 49 | ABL2 | 1.12345782 |
| 50 | LYN | 1.10524470 |
| 51 | JAK2 | 1.07871909 |
| 52 | TGFBR1 | 1.04279766 |
| 53 | GSK3A | 1.02273803 |
| 54 | TYRO3 | 0.99042346 |
| 55 | PRKD2 | 0.97370940 |
| 56 | CAMK1G | 0.97194101 |
| 57 | NEK9 | 0.94497444 |
| 58 | EPHB1 | 0.94203440 |
| 59 | CHUK | 0.94063049 |
| 60 | PDK2 | 0.94009637 |
| 61 | TAOK3 | 0.93458130 |
| 62 | DAPK1 | 0.93354852 |
| 63 | RPS6KC1 | 0.92239587 |
| 64 | RPS6KL1 | 0.92239587 |
| 65 | HCK | 0.88188484 |
| 66 | EGFR | 0.87795742 |
| 67 | IRAK2 | 0.86712030 |
| 68 | IRAK1 | 0.86336979 |
| 69 | RPS6KA6 | 0.85578016 |
| 70 | TXK | 0.84916189 |
| 71 | PDPK1 | 0.83145213 |
| 72 | JAK3 | 0.81816069 |
| 73 | LCK | 0.79626508 |
| 74 | FRK | 0.76568879 |
| 75 | INSRR | 0.76097068 |
| 76 | PRKAA2 | 0.75592455 |
| 77 | BCKDK | 0.73214219 |
| 78 | SIK2 | 0.70492527 |
| 79 | SIK1 | 0.68999780 |
| 80 | MAP2K6 | 0.67980591 |
| 81 | ITK | 0.67247717 |
| 82 | PDK1 | 0.66262637 |
| 83 | STK10 | 0.65617178 |
| 84 | STK3 | 0.60825057 |
| 85 | MAP3K2 | 0.57732846 |
| 86 | PDGFRB | 0.55391782 |
| 87 | MAP2K3 | 0.54901002 |
| 88 | MARK2 | 0.53041560 |
| 89 | PRKAA1 | 0.52723013 |
| 90 | DAPK2 | 0.52444894 |
| 91 | PBK | 0.52314359 |
| 92 | CAMKK1 | 0.51312422 |
| 93 | ABL1 | 0.50973463 |
| 94 | MAP3K13 | 0.50654533 |
| 95 | MOS | 0.50024863 |
| 96 | MAPK12 | 0.49883367 |
| 97 | AKT3 | 0.48915028 |
| 98 | MAPK7 | 0.48481208 |
| 99 | SYK | 0.47844848 |
| 100 | MAPK4 | 0.47197755 |
| 101 | TEC | 0.47060650 |
| 102 | LATS1 | 0.46526411 |
| 103 | MAP3K10 | 0.46290318 |
| 104 | EIF2AK2 | 0.46044850 |
| 105 | PTK6 | 0.45026065 |
| 106 | PRKCD | 0.44554124 |
| 107 | TESK2 | 0.43861712 |
| 108 | CDC42BPA | 0.43707843 |
| 109 | INSR | 0.42251562 |
| 110 | KSR2 | 0.42212903 |
| 111 | RPS6KA2 | 0.41342683 |
| 112 | BTK | 0.41163984 |
| 113 | RPS6KA1 | 0.41078353 |
| 114 | PRKG2 | 0.40016495 |
| 115 | MTOR | 0.39890461 |
| 116 | PIK3CG | 0.39325860 |
| 117 | ADRBK2 | 0.38624976 |
| 118 | GRK6 | 0.37925495 |
| 119 | MAPKAPK2 | 0.37078283 |
| 120 | CAMK4 | 0.35482201 |
| 121 | MAP3K5 | 0.33593129 |
| 122 | FYN | 0.32502847 |
| 123 | FGFR3 | 0.32365444 |
| 124 | EPHB2 | 0.32027989 |
| 125 | SIK3 | 0.31938187 |
| 126 | PRKCZ | 0.31880124 |
| 127 | MAPK3 | 0.30814340 |
| 128 | RIPK1 | 0.30794000 |
| 129 | PAK2 | 0.30165117 |
| 130 | CDK7 | 0.29791991 |
| 131 | BMPR2 | 0.29532217 |
| 132 | KSR1 | 0.29436890 |
| 133 | ARAF | 0.29436657 |
| 134 | CLK1 | 0.29134427 |
| 135 | STK4 | 0.29019102 |
| 136 | SGK3 | 0.28824358 |
| 137 | EPHA3 | 0.28172657 |
| 138 | CDK12 | 0.27959502 |
| 139 | PRKCQ | 0.27783579 |
| 140 | IGF1R | 0.27059085 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.95269096 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.05041134 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.04694703 |
| 4 | Asthma_Homo sapiens_hsa05310 | 2.53960343 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.49880961 |
| 6 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.42934314 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.42457154 |
| 8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.40311230 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.30934199 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.24784305 |
| 11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.21407725 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.14410373 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.96841762 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.93185654 |
| 15 | Lysosome_Homo sapiens_hsa04142 | 1.82016336 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.71639255 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.64982721 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.63456589 |
| 19 | Other glycan degradation_Homo sapiens_hsa00511 | 1.56462518 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.55894417 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.54191977 |
| 22 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.52265456 |
| 23 | Leishmaniasis_Homo sapiens_hsa05140 | 1.46898137 |
| 24 | ABC transporters_Homo sapiens_hsa02010 | 1.42311583 |
| 25 | Pertussis_Homo sapiens_hsa05133 | 1.41688719 |
| 26 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.41558642 |
| 27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.40604577 |
| 28 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.40279146 |
| 29 | Legionellosis_Homo sapiens_hsa05134 | 1.39250152 |
| 30 | Prion diseases_Homo sapiens_hsa05020 | 1.38327648 |
| 31 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.38167970 |
| 32 | Peroxisome_Homo sapiens_hsa04146 | 1.26743812 |
| 33 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.22458103 |
| 34 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.18475313 |
| 35 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.17890752 |
| 36 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.17055254 |
| 37 | Lysine degradation_Homo sapiens_hsa00310 | 1.16924887 |
| 38 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.16853949 |
| 39 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.16609355 |
| 40 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.14281716 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.08082140 |
| 42 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.06708663 |
| 43 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.05919943 |
| 44 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.05333334 |
| 45 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.02353082 |
| 46 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.01552074 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.00838527 |
| 48 | Tuberculosis_Homo sapiens_hsa05152 | 0.99948417 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.99453337 |
| 50 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.98081632 |
| 51 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.97556859 |
| 52 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.96330135 |
| 53 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.95176691 |
| 54 | Histidine metabolism_Homo sapiens_hsa00340 | 0.94612694 |
| 55 | Measles_Homo sapiens_hsa05162 | 0.93292177 |
| 56 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.92345761 |
| 57 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.92017529 |
| 58 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.91784490 |
| 59 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.91510317 |
| 60 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.91239877 |
| 61 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.88837742 |
| 62 | Retinol metabolism_Homo sapiens_hsa00830 | 0.87611144 |
| 63 | Malaria_Homo sapiens_hsa05144 | 0.86934542 |
| 64 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.81390631 |
| 65 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.81187121 |
| 66 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.80884609 |
| 67 | Influenza A_Homo sapiens_hsa05164 | 0.77294168 |
| 68 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.76344022 |
| 69 | Allograft rejection_Homo sapiens_hsa05330 | 0.76036658 |
| 70 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.75030537 |
| 71 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.73542233 |
| 72 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.73505191 |
| 73 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70641984 |
| 74 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.70567813 |
| 75 | Bile secretion_Homo sapiens_hsa04976 | 0.70036585 |
| 76 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.69053433 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67484670 |
| 78 | Platelet activation_Homo sapiens_hsa04611 | 0.66777665 |
| 79 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.66698692 |
| 80 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.65768231 |
| 81 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.65581353 |
| 82 | Hepatitis C_Homo sapiens_hsa05160 | 0.65554305 |
| 83 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.65523050 |
| 84 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.65069178 |
| 85 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.64505945 |
| 86 | Amoebiasis_Homo sapiens_hsa05146 | 0.63149077 |
| 87 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.61177538 |
| 88 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.60649313 |
| 89 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.60420388 |
| 90 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.59191555 |
| 91 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.59081336 |
| 92 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.58343425 |
| 93 | Phagosome_Homo sapiens_hsa04145 | 0.57482332 |
| 94 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.56895028 |
| 95 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.56878268 |
| 96 | Salmonella infection_Homo sapiens_hsa05132 | 0.56359501 |
| 97 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.56151867 |
| 98 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.55714408 |
| 99 | Hepatitis B_Homo sapiens_hsa05161 | 0.55686369 |
| 100 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.55295983 |
| 101 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.54784639 |
| 102 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.54111804 |
| 103 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.53980274 |
| 104 | Galactose metabolism_Homo sapiens_hsa00052 | 0.53372465 |
| 105 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.52350143 |
| 106 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.50511103 |
| 107 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.50221657 |
| 108 | Shigellosis_Homo sapiens_hsa05131 | 0.49204183 |
| 109 | Mineral absorption_Homo sapiens_hsa04978 | 0.48931106 |
| 110 | Viral myocarditis_Homo sapiens_hsa05416 | 0.48383374 |
| 111 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48320650 |
| 112 | Adherens junction_Homo sapiens_hsa04520 | 0.48258445 |
| 113 | Apoptosis_Homo sapiens_hsa04210 | 0.48142405 |
| 114 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.45272143 |
| 115 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.44881051 |
| 116 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.44268490 |
| 117 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.43938165 |
| 118 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.43784801 |
| 119 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.43168150 |
| 120 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.42053179 |
| 121 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41924318 |
| 122 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.40349115 |
| 123 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39391108 |
| 124 | Endocytosis_Homo sapiens_hsa04144 | 0.38977264 |
| 125 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.38910982 |
| 126 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.38829952 |
| 127 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.38806509 |
| 128 | Bladder cancer_Homo sapiens_hsa05219 | 0.38449407 |
| 129 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.36542017 |
| 130 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.35617740 |
| 131 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.35614192 |
| 132 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.34595778 |
| 133 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.34445251 |
| 134 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.33800105 |
| 135 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.32486786 |
| 136 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.32183687 |
| 137 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.29597771 |
| 138 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.27857345 |
| 139 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.27713650 |
| 140 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.26460432 |
| 141 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.26080247 |
| 142 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.25318996 |
| 143 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.24715041 |
| 144 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.23192084 |
| 145 | Renin secretion_Homo sapiens_hsa04924 | 0.19819733 |
| 146 | HTLV-I infection_Homo sapiens_hsa05166 | 0.18948735 |
| 147 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.18656300 |
| 148 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.16405513 |
| 149 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.16268429 |
| 150 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.13929560 |

